Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 10 |
| 1.1 List of Tables | 6 | 5 |
| 1.2 List of Figures | 11 | 1 |
| 2 Introduction | 12 | 1 |
| 2.1 External Remote Patient Monitoring Devices Overview | 12 | 1 |
| 3 Products under Development | 13 | 5 |
| 3.1 External Remote Patient Monitoring Devices - Pipeline Products by Stage of Development | 13 | 1 |
| 3.2 External Remote Patient Monitoring Devices - Pipeline Products by Territory | 14 | 1 |
| 3.3 External Remote Patient Monitoring Devices - Pipeline Products by Regulatory Path | 15 | 1 |
| 3.4 External Remote Patient Monitoring Devices - Pipeline Products by Estimated Approval Date | 16 | 1 |
| 3.5 External Remote Patient Monitoring Devices - Ongoing Clinical Trials | 17 | 1 |
| 4 External Remote Patient Monitoring Devices - Pipeline Products under Development by Companies | 18 | 6 |
| 4.1 External Remote Patient Monitoring Devices Companies - Pipeline Products by Stage of Development | 18 | 3 |
| 4.2 External Remote Patient Monitoring Devices - Pipeline Products by Stage of Development | 21 | 3 |
| 5 External Remote Patient Monitoring Devices Companies and Product Overview | 24 | 98 |
| 5.1 A*STAR Institute of Microelectronics Company Overview | 24 | 1 |
| 5.1.1 A*STAR Institute of Microelectronics Pipeline Products &Ongoing Clinical Trials Overview | 24 | 1 |
| 5.2 ActiveCare, Inc. Company Overview | 25 | 1 |
| 5.2.1 ActiveCare, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 25 | 2 |
| 5.3 Agali Technologies, Inc. Company Overview | 27 | 1 |
| 5.3.1 Agali Technologies, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 27 | 2 |
| 5.4 AirStrip Technologies, Inc. Company Overview | 29 | 1 |
| 5.4.1 AirStrip Technologies, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 29 | 1 |
| 5.5 ALR Technologies Inc. Company Overview | 30 | 1 |
| 5.5.1 ALR Technologies Inc. Pipeline Products &Ongoing Clinical Trials Overview | 30 | 6 |
| 5.6 Apogee Technology, Inc. Company Overview | 36 | 1 |
| 5.6.1 Apogee Technology, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 36 | 1 |
| 5.7 ARC Devices Ltd. Company Overview | 37 | 1 |
| 5.7.1 ARC Devices Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 37 | 1 |
| 5.8 Aseptika Ltd Company Overview | 38 | 1 |
| 5.8.1 Aseptika Ltd Pipeline Products &Ongoing Clinical Trials Overview | 38 | 1 |
| 5.9 Barron Associates, Inc. Company Overview | 39 | 1 |
| 5.9.1 Barron Associates, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 39 | 3 |
| 5.10 Baylor College of Medicine Company Overview | 42 | 1 |
| 5.10.1 Baylor College of Medicine Pipeline Products &Ongoing Clinical Trials Overview | 42 | 1 |
| 5.11 BioSensics LLC Company Overview | 43 | 1 |
| 5.11.1 BioSensics LLC Pipeline Products &Ongoing Clinical Trials Overview | 43 | 1 |
| 5.12 Boston Scientific Corporation Company Overview | 44 | 1 |
| 5.12.1 Boston Scientific Corporation Pipeline Products &Ongoing Clinical Trials Overview | 44 | 2 |
| 5.13 Brain Tunnelgenix Technologies Corp. Company Overview | 46 | 1 |
| 5.13.1 Brain Tunnelgenix Technologies Corp. Pipeline Products &Ongoing Clinical Trials Overview | 46 | 1 |
| 5.14 BrightOutcome Inc. Company Overview | 47 | 1 |
| 5.14.1 BrightOutcome Inc. Pipeline Products &Ongoing Clinical Trials Overview | 47 | 2 |
| 5.15 CorTronix Biomedical Advancement Technologies, Inc. Company Overview | 49 | 1 |
| 5.15.1 CorTronix Biomedical Advancement Technologies, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 49 | 1 |
| 5.16 Dartmouth College Company Overview | 50 | 1 |
| 5.16.1 Dartmouth College Pipeline Products &Ongoing Clinical Trials Overview | 50 | 1 |
| 5.17 Deep Breeze Ltd. (Inactive) Company Overview | 51 | 1 |
| 5.17.1 Deep Breeze Ltd. (Inactive) Pipeline Products &Ongoing Clinical Trials Overview | 51 | 1 |
| 5.18 Eccrine Systems, Inc. Company Overview | 52 | 1 |
| 5.18.1 Eccrine Systems, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 52 | 1 |
| 5.19 Freescale Semiconductor, Ltd. (Inactive) Company Overview | 53 | 1 |
| 5.19.1 Freescale Semiconductor, Ltd. (Inactive) Pipeline Products &Ongoing Clinical Trials Overview | 53 | 2 |
| 5.20 Great Lakes NeuroTechnologies Inc Company Overview | 55 | 1 |
| 5.20.1 Great Lakes NeuroTechnologies Inc Pipeline Products &Ongoing Clinical Trials Overview | 55 | 3 |
| 5.21 Grey Innovation Pty Ltd Company Overview | 58 | 1 |
| 5.21.1 Grey Innovation Pty Ltd Pipeline Products &Ongoing Clinical Trials Overview | 58 | 1 |
| 5.22 Guide Analytics Inc. Company Overview | 59 | 1 |
| 5.22.1 Guide Analytics Inc. Pipeline Products &Ongoing Clinical Trials Overview | 59 | 1 |
| 5.23 iBeat Inc Company Overview | 60 | 1 |
| 5.23.1 iBeat Inc Pipeline Products &Ongoing Clinical Trials Overview | 60 | 1 |
| 5.24 Ibridge Medical, LLC Company Overview | 61 | 1 |
| 5.24.1 Ibridge Medical, LLC Pipeline Products &Ongoing Clinical Trials Overview | 61 | 1 |
| 5.25 Inspire Living, Inc Company Overview | 62 | 1 |
| 5.25.1 Inspire Living, Inc Pipeline Products &Ongoing Clinical Trials Overview | 62 | 1 |
| 5.26 John Hopkins University Company Overview | 63 | 1 |
| 5.26.1 John Hopkins University Pipeline Products &Ongoing Clinical Trials Overview | 63 | 2 |
| 5.27 JointMetrix Medical, LLC Company Overview | 65 | 1 |
| 5.27.1 JointMetrix Medical, LLC Pipeline Products &Ongoing Clinical Trials Overview | 65 | 1 |
| 5.28 Kimberly-Clark Corporation Company Overview | 66 | 1 |
| 5.28.1 Kimberly-Clark Corporation Pipeline Products &Ongoing Clinical Trials Overview | 66 | 2 |
| 5.29 Kyma Medical Technologies Ltd Company Overview | 68 | 1 |
| 5.29.1 Kyma Medical Technologies Ltd Pipeline Products &Ongoing Clinical Trials Overview | 68 | 5 |
| 5.30 Lifelong Technologies, LLC Company Overview | 73 | 1 |
| 5.30.1 Lifelong Technologies, LLC Pipeline Products &Ongoing Clinical Trials Overview | 73 | 1 |
| 5.31 Michigan State University Company Overview | 74 | 1 |
| 5.31.1 Michigan State University Pipeline Products &Ongoing Clinical Trials Overview | 74 | 1 |
| 5.32 Montana State University Company Overview | 75 | 1 |
| 5.32.1 Montana State University Pipeline Products &Ongoing Clinical Trials Overview | 75 | 1 |
| 5.33 OBS Medical Ltd. Company Overview | 76 | 1 |
| 5.33.1 OBS Medical Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 76 | 2 |
| 5.34 Panasonic Corporation Company Overview | 78 | 1 |
| 5.34.1 Panasonic Corporation Pipeline Products &Ongoing Clinical Trials Overview | 78 | 2 |
| 5.35 PerGenix LLC Company Overview | 80 | 1 |
| 5.35.1 PerGenix LLC Pipeline Products &Ongoing Clinical Trials Overview | 80 | 1 |
| 5.36 Philips Healthcare Company Overview | 81 | 1 |
| 5.36.1 Philips Healthcare Pipeline Products &Ongoing Clinical Trials Overview | 81 | 5 |
| 5.37 Rethink Medical, Inc. Company Overview | 86 | 1 |
| 5.37.1 Rethink Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 86 | 1 |
| 5.38 Rowan University Company Overview | 87 | 1 |
| 5.38.1 Rowan University Pipeline Products &Ongoing Clinical Trials Overview | 87 | 1 |
| 5.39 Sensaris Company Overview | 88 | 1 |
| 5.39.1 Sensaris Pipeline Products &Ongoing Clinical Trials Overview | 88 | 1 |
| 5.40 Sensogo Ltd. Company Overview | 89 | 1 |
| 5.40.1 Sensogo Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 89 | 1 |
| 5.41 Seoul National University Hospital Company Overview | 90 | 1 |
| 5.41.1 Seoul National University Hospital Pipeline Products &Ongoing Clinical Trials Overview | 90 | 2 |
| 5.42 Sister Kenny Research Center Company Overview | 92 | 1 |
| 5.42.1 Sister Kenny Research Center Pipeline Products &Ongoing Clinical Trials Overview | 92 | 1 |
| 5.43 SPO Global Inc. Company Overview | 93 | 1 |
| 5.43.1 SPO Global Inc. Pipeline Products &Ongoing Clinical Trials Overview | 93 | 2 |
| 5.44 Teva Pharmaceutical Industries Ltd. Company Overview | 95 | 1 |
| 5.44.1 Teva Pharmaceutical Industries Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 95 | 2 |
| 5.45 Universitat Politecnica de Catalunya Company Overview | 97 | 1 |
| 5.45.1 Universitat Politecnica de Catalunya Pipeline Products &Ongoing Clinical Trials Overview | 97 | 3 |
| 5.46 University of California, Berkeley Company Overview | 100 | 1 |
| 5.46.1 University of California, Berkeley Pipeline Products &Ongoing Clinical Trials Overview | 100 | 1 |
| 5.47 University of California, Los Angeles Company Overview | 101 | 1 |
| 5.47.1 University of California, Los Angeles Pipeline Products &Ongoing Clinical Trials Overview | 101 | 2 |
| 5.48 University of Colorado Company Overview | 103 | 1 |
| 5.48.1 University of Colorado Pipeline Products &Ongoing Clinical Trials Overview | 103 | 1 |
| 5.49 University of Illinois at Chicago Company Overview | 104 | 1 |
| 5.49.1 University of Illinois at Chicago Pipeline Products &Ongoing Clinical Trials Overview | 104 | 1 |
| 5.50 University of Michigan Pediatric Device Consortium Company Overview | 105 | 1 |
| 5.50.1 University of Michigan Pediatric Device Consortium Pipeline Products &Ongoing Clinical Trials Overview | 105 | 1 |
| 5.51 University of Missouri Company Overview | 106 | 1 |
| 5.51.1 University of Missouri Pipeline Products &Ongoing Clinical Trials Overview | 106 | 1 |
| 5.52 University of New Mexico Company Overview | 107 | 1 |
| 5.52.1 University of New Mexico Pipeline Products &Ongoing Clinical Trials Overview | 107 | 1 |
| 5.53 University of Oxford Company Overview | 108 | 1 |
| 5.53.1 University of Oxford Pipeline Products &Ongoing Clinical Trials Overview | 108 | 1 |
| 5.54 University of Toronto Company Overview | 109 | 1 |
| 5.54.1 University of Toronto Pipeline Products &Ongoing Clinical Trials Overview | 109 | 2 |
| 5.55 VivaLnk, Inc. Company Overview | 111 | 1 |
| 5.55.1 VivaLnk, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 111 | 1 |
| 5.56 Vivometrics, Inc. Company Overview | 112 | 1 |
| 5.56.1 Vivometrics, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 112 | 1 |
| 5.57 Waldo Health Company Overview | 113 | 1 |
| 5.57.1 Waldo Health Pipeline Products &Ongoing Clinical Trials Overview | 113 | 1 |
| 5.58 WANDA Inc Company Overview | 114 | 1 |
| 5.58.1 WANDA Inc Pipeline Products &Ongoing Clinical Trials Overview | 114 | 2 |
| 5.59 Washington State University Company Overview | 116 | 1 |
| 5.59.1 Washington State University Pipeline Products &Ongoing Clinical Trials Overview | 116 | 2 |
| 5.60 Wave Technology Group, Inc. (Inactive) Company Overview | 118 | 1 |
| 5.60.1 Wave Technology Group, Inc. (Inactive) Pipeline Products &Ongoing Clinical Trials Overview | 118 | 1 |
| 5.61 Welch Allyn Inc. Company Overview | 119 | 1 |
| 5.61.1 Welch Allyn Inc. Pipeline Products &Ongoing Clinical Trials Overview | 119 | 1 |
| 5.62 Xhale, Inc. Company Overview | 120 | 1 |
| 5.62.1 Xhale, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 120 | 2 |
| 6 External Remote Patient Monitoring Devices- Recent Developments | 122 | 8 |
| 6.1 Sep 09, 2016: Tunstall Announces New Chief Executive Officer | 122 | 1 |
| 6.2 Aug 26, 2016: ActiveCare Announces Third Quarter Financial Results | 122 | 1 |
| 6.3 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 | 122 | 2 |
| 6.4 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors | 124 | 1 |
| 6.5 Jul 01, 2016: New AutoFALL Medical Alert Pendant Signals For Help If You Fall | 124 | 1 |
| 6.6 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation | 125 | 1 |
| 6.7 May 16, 2016: Tactio &Redox Team Up to Integrate TactioRPM With North American EHRs | 126 | 1 |
| 6.8 Mar 23, 2016: Renowned scientist will lead rare mission to address the epidemic of heart failure | 126 | 1 |
| 6.9 Feb 17, 2016: Precision Image Analysis Announces Agreements with toSense and Erasmus University | 127 | 1 |
| 6.10 Jan 20, 2016: Philips Lifeline s New GoSafe Mobile Technology Keeps Seniors Connected to Emergency Care On-the-Go | 127 | 1 |
| 6.11 Nov 17, 2015: ALRT System Significantly Lowers A1C Levels in Type 2 Diabetes Patients in Real World Pilot Program | 128 | 1 |
| 6.12 Oct 05, 2015: University of Michigan Selects Tactio Remote Patient Monitoring Platform to Support Clinical Pharmacist Management of Patients With Uncontrolled Hypertension | 128 | 2 |
| 7 Appendix | 130 | 4 |
| 7.1 Methodology | 130 | 2 |
| 7.2 About GlobalData | 132 | 1 |
| 7.3 Contact Us | 132 | 1 |
| 7.4 Disclaimer | 133 | 1 |
